Intelligence Β· Clinical Pipeline

Sana Biotechnology Pipeline

All ClinicalTrials.gov programs at Sana Biotechnology β€” phase, modality, and trial IDs.

Programs
5

Quick answer

Sana Biotechnology has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Methotrexate

    Sana Biotechnology

    Chronic Plaque Psoriasis

    phase 1 small molecule active

    1 trial
  2. SC262

    Sana Biotechnology

    Non Hodgkin's Lymphoma

    phase 1 small molecule active

    1 trial
  3. SC291

    Sana Biotechnology

    Lupus Erythematosus

    phase 1 mab active

    1 trial
  4. SC291

    Sana Biotechnology

    Non Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial
  5. UP421

    Sana Biotechnology

    Type1diabetes

    phase 1 mab active

    1 trial

Frequently asked questions

How many pipeline programs does Sana Biotechnology have?

5 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs